TRT Monitoring Blood Tests And How Often To Get Them

TRT monitoring is the routine blood work that helps confirm whether testosterone therapy is reaching its goal and flags side effects early. A standard panel checks testosterone, hematocrit, prostate-specific antigen, estradiol, a lipid panel, and metabolic markers, repeated at set points through the first year and annually after that.

The reason it matters is more concrete than most men expect. In a 2025 single-center study of 247 men on testosterone therapy, 23 percent crossed a hematocrit of 50 percent and 5 percent went past 54 percent, the level where guidelines call for action (Neidhart et al., 2025). Marek Health runs testosterone therapy as a telehealth service, and every plan rests on lab-based hormone care and provider review, not a one-time prescription.

Why does TRT monitoring matter?

Testosterone therapy changes more than one number. It can raise red blood cell production, shift estradiol, and affect the prostate and cholesterol, and, per a February 2025 FDA labeling update, can raise blood pressure across testosterone products (FDA, 2025). The TRAVERSE trial behind that update, run in men with existing or high cardiovascular risk, found testosterone was noninferior to placebo for major cardiac events, meaning it did not show a higher rate in this trial, though more atrial fibrillation and pulmonary embolism were seen in the testosterone group (Lincoff et al., 2023). Blood tests are how a provider sees those shifts in time to act.

Monitoring does three things: it confirms testosterone has reached the target range, it catches side effects like rising hematocrit before they carry real risk, and it tells the provider whether the dose needs to change.

There's a quieter fourth reason. A lab value on its own doesn't decide treatment. The AUA is direct about this: if testosterone reaches target but symptoms don't improve, it advises stopping therapy, since the symptoms may have another cause (Mulhall et al., 2018). Reading symptoms against reference ranges is the real skill, not chasing one figure. Men who skip monitoring take on avoidable risk: a hematocrit that climbs unnoticed, prostate changes nobody checked for, or a dose that never gets corrected for diagnosed hypogonadism.

What's on a standard TRT blood panel?

A standard panel covers six areas. Here's what each test reads and why it earns a place on the order.

Total and free testosterone

These show whether therapy has moved testosterone into range. Total testosterone counts everything in the blood, bound and free; free testosterone is the small fraction not bound to proteins and available to tissue. The AUA target is the middle of the normal range, 450 to 600 ng/dL, reached with the lowest dose that also resolves symptoms (Mulhall et al., 2018). Levels under that suggest an underdose. Levels well above the target range can add side effects without clear added benefit for many men. When symptoms and total testosterone disagree, free and total testosterone read together with SHBG can help explain the gap.

Hematocrit and hemoglobin

This is the side effect to watch most closely. Hematocrit is the share of blood made up of red cells; hemoglobin is the protein in them that carries oxygen. Both come from a complete blood count. Testosterone tells the bone marrow to make more red cells, which can raise hematocrit. That rise may increase blood thickness and has been associated with a higher clotting risk in some men. The Endocrine Society sets the action line at 54 percent: above it, hold therapy until levels fall, check for obstructive sleep apnea and low oxygen, then restart at a lower dose (Bhasin et al., 2018). The AUA treats a hematocrit over 50 percent as a reason to investigate before going further (Mulhall et al., 2018). Managing elevated hematocrit is routine, not cause for panic, but it only works if someone is measuring it.

Prostate-specific antigen (PSA)

PSA is a protein the prostate makes, and testosterone can stimulate prostate tissue. The TRAVERSE prostate substudy found no significant difference in high-grade or any prostate cancer between the testosterone and placebo groups (Bhasin et al., 2023), but PSA is monitored over time so any change can be evaluated, as part of a shared decision about prostate screening. During the first 12 months, the Endocrine Society recommends a urological referral if PSA rises by more than 1.4 ng/mL, if a confirmed PSA passes 4.0 ng/mL, or if a rectal exam is abnormal (Bhasin et al., 2018). For men over 40, the AUA recommends a baseline PSA before starting, as part of shared decision-making about prostate screening (Mulhall et al., 2018).

Estradiol

Some testosterone converts to estradiol, the main estrogen in men, through a process called aromatization. Higher testosterone can mean higher estradiol, and high estradiol can bring water retention, mood changes, or breast tissue growth. Contrary to common online advice, no major guideline sets a target estradiol number for men on testosterone, and plenty of men feel fine at levels a lab flags as high. Symptoms drive the decision, not the figure alone. One detail does matter: estradiol in men is best run with a sensitive (LC-MS/MS) assay, because the standard immunoassay is unreliable at male ranges. Sensitive estradiol testing is the version worth ordering.

Lipid panel

A lipid panel reads total cholesterol, LDL, HDL, and triglycerides. Testosterone therapy can affect cholesterol, sometimes lowering HDL, though the heart-health meaning of this change during therapy is not fully clear. A drop in HDL or rise in LDL is a conversation with your provider about heart risk, not an automatic stop.

Metabolic and liver markers (CMP)

A CMP reads liver enzymes, kidney markers, glucose, and electrolytes. The old worry was liver strain from oral testosterone, but that came from the 17-alpha-alkylated androgens of decades past, not today's FDA-approved oral testosterone undecanoate, which isn't linked to that kind of liver injury. Its label flags blood pressure instead (FDA, 2025). Injectable and topical testosterone rarely touch liver enzymes. The CMP is a wide net for anything unexpected.

How often should you get blood work on TRT?

Most of the testing happens in the first year, then settles into an annual rhythm. The schedule below follows AUA and Endocrine Society guidance: a full baseline, a recheck at three to six months once levels are near steady state, a twelve-month review, and annual labs after that (Mulhall et al., 2018; Bhasin et al., 2018).

The first year often runs tighter than this, especially when a dose is still being adjusted or a baseline hematocrit was already high. What gets tested, and how often, is tailored by your provider to your history and response. Diagnosis itself rests on two separate early-morning testosterone draws plus symptoms, not one number on one day (Bhasin et al., 2018).

When should you time your blood draw?

Time of day and timing within your dose both change the result, so consistency is what matters most. Draw in the morning, between 7 and 10 AM, when testosterone naturally peaks; this is also when the diagnostic draws are taken (Bhasin et al., 2018).

For weekly injections, a mid-cycle draw (three to four days after the shot) gives a representative level, while a draw right before the next injection shows your trough, the lowest point. Your provider may want one or both. For gels or patches, test two to four hours after applying for a peak, or before applying for a trough.

The rule under all of it: test at the same point in your cycle every time, or the numbers can't be compared.

Red flags worth a call to your provider

A few results mean calling sooner rather than waiting for the next scheduled lab:

• Hematocrit above 54 percent, which your provider may address by pausing or lowering the dose and looking for contributing causes (Bhasin et al., 2018).

• A PSA rise over 1.4 ng/mL in the first 12 months, or a confirmed PSA above 4.0 ng/mL (Bhasin et al., 2018).

• Testosterone well above your target range with no added symptom relief.

• Estradiol that's high and symptomatic, with breast tenderness, puffiness, or mood swings.

• A clear jump in liver enzymes.

None of these automatically means stopping therapy. They mean the plan needs a look, usually a dose change or a closer evaluation, decided with your provider based on your labs.

Tests some men need beyond the core panel

The core panel covers most men. Some need more.

LH and FSH usually get checked at diagnosis, not during therapy. On testosterone they drop, because outside testosterone signals the brain to stop telling the testes to work, so low LH and FSH on TRT is expected. They matter again if fertility while on TRT is the goal, since that suppression can lower sperm production and isn't guaranteed to reverse (Mulhall et al., 2018). Prolactin gets checked when testosterone stays low on an adequate dose or pituitary issues are suspected. SHBG helps when symptoms and testosterone don't line up, since it sets how much testosterone is actually free. Thyroid panels come in when fatigue or low drive persists at a good testosterone level.

Can you monitor TRT at home?

Partly. At-home kits cover the common markers (testosterone, hematocrit and hemoglobin, PSA, estradiol, basic metabolic values) from a morning finger-prick sample mailed to a certified lab, with results online in a few days. They're good for tracking trends between visits.

They don't replace the full picture. Diagnosis and dose decisions rest on standardized venous draws and a provider's read, and a few markers are simply more reliable from a venous sample. With a telehealth provider, testosterone is prescribed only after evaluation and lab confirmation, and only when it's medically appropriate, which is the part no home kit handles. Done right, TRT monitoring is the combination: convenient at-home checks between visits, plus standardized labs and provider review for the decisions that count.

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

What blood tests are included in TRT monitoring? 

A standard TRT panel checks total and free testosterone, a complete blood count for hematocrit and hemoglobin, prostate-specific antigen, estradiol, a lipid panel, and a metabolic panel (CMP). The AUA target for testosterone is the middle of the normal range, roughly 450 to 600 ng/dL, reached with the lowest dose that also relieves symptoms. Your provider decides which markers to repeat at each visit.

How often do you need blood work on TRT? 

Guidelines point to a full baseline before starting, a recheck at three to six months once levels are steady, a review at twelve months, and annual labs after that. The first year often runs tighter, especially while a dose is still being adjusted or if baseline hematocrit was already high. Testosterone diagnosis itself uses two separate morning draws plus symptoms.

What hematocrit level is too high on TRT? 

The Endocrine Society sets the action line at a hematocrit above 54 percent, where therapy is held until levels fall, then restarted at a lower dose after checking for sleep apnea. The AUA treats a hematocrit over 50 percent as a reason to investigate before continuing. In a 2025 single-center study of 247 men on testosterone, 23 percent passed 50 percent and 5 percent passed 54 percent.

Does TRT raise PSA or cause prostate cancer? 

A 2023 randomized trial, the TRAVERSE prostate substudy, found no significant difference in high-grade or any prostate cancer between men on testosterone and men on placebo, but PSA is monitored over time so any change can be evaluated, as part of a shared decision about prostate screening. The Endocrine Society recommends a urology referral if PSA rises by more than 1.4 ng/mL within the first 12 months, if a confirmed PSA passes 4.0 ng/mL, or if a rectal exam is abnormal. For men over 40, the AUA recommends a baseline PSA before starting, as part of shared decision-making about prostate screening.

When should I get my blood drawn for TRT monitoring? 

Draw in the morning between 7 and 10 AM, when testosterone naturally peaks. For weekly injections, a draw three to four days after the shot gives a representative level, while a draw just before the next shot shows the trough. Testing at the same point in your cycle each time is what makes results comparable.

Can I do TRT monitoring at home? 

At-home kits cover common markers from a morning finger-prick sample sent to a certified lab, which is useful for tracking trends between visits. They do not replace standardized venous draws and provider review, which is what diagnosis and dose decisions rest on. At-home testing supplements a monitoring schedule rather than running it alone.

What estradiol level matters on TRT? 

No major guideline sets a target estradiol number for men on testosterone, and many men feel fine at levels a lab flags as high, so symptoms guide the decision more than the figure. Estradiol in men is best measured with a sensitive (LC-MS/MS) assay, because the standard immunoassay is unreliable at male ranges. Water retention, mood changes, or breast tenderness are the signals that matter.

References

• FDA. Class-wide labeling changes for testosterone products. February 28, 2025

• Front Endocrinol (Lausanne). 2025;15:1496906

• J Clin Endocrinol Metab. 2018;103(5):1715–1744

• J Urol. 2018;200(2):423–432

• JAMA Netw Open. 2023;6(12):e2348692

• N Engl J Med. 2023;389(2):107–117